Search hospitals > Kansas > Mission
University of Kansas Medical Center
Claim this profileMission, Kansas 66205
Global Leader in Adult T-Cell Leukemia/Lymphoma
Conducts research for Myeloid Leukemia
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Acute Myelogenous Leukemia
59 reported clinical trials
5 medical researchers
Summary
University of Kansas Medical Center is a medical facility located in Mission, Kansas. This center is recognized for care of Adult T-Cell Leukemia/Lymphoma, Myeloid Leukemia, Lung Cancer, Non-Small Cell Lung Cancer, Acute Myelogenous Leukemia and other specialties. University of Kansas Medical Center is involved with conducting 59 clinical trials across 88 conditions. There are 5 research doctors associated with this hospital, such as Andrea D. Jewell, Raed Al-Rajabi, Steve Williamson, MD, and OBI Investigator Site.Area of expertise
1Adult T-Cell Leukemia/Lymphoma
Global LeaderPhiladelphia chromosome positive
CD19 positive
2Myeloid Leukemia
Top PIs
Andrea D. JewellUniversity of Kansas Cancer Center5 years of reported clinical research
Expert in Ovarian Cancer
Studies Fallopian Tube Cancer
18 reported clinical trials
39 drugs studied
Raed Al-RajabiUniversity of Kansas Cancer Center-Overland Park8 years of reported clinical research
Studies Parotid Gland Cancer
Studies Liver Cancer
11 reported clinical trials
17 drugs studied
Steve Williamson, MDThe University of Kansas Cancer Center (KUCC)3 years of reported clinical research
Studies Breast Cancer
Studies Non-Small Cell Lung Cancer
5 reported clinical trials
8 drugs studied
OBI Investigator SiteKaiser Permanente Medical Center6 years of reported clinical research
Studies Breast Cancer
Studies Pancreatic Adenocarcinoma
2 reported clinical trials
3 drugs studied
Clinical Trials running at University of Kansas Medical Center
Cancer
Liver Cancer
Multiple Myeloma
Lymphoma
Bladder Cancer
Follicular Lymphoma
Chronic Lymphocytic Leukemia
Mantle Cell Lymphoma
Non-Small Cell Lung Cancer
Breast Cancer
MRTX849
for Cancer
This trial is testing a new pill called MRTX849 (adagrasib) for patients with advanced cancers that have a specific genetic change called KRAS G12C. The pill aims to block this change and stop the cancer from growing. Adagrasib is similar to another approved treatment and is intended for patients with this genetic change who have already received other treatments.
Recruiting1 award Phase 1 & 24 criteria
ASP3082
for Cancer
This trial is testing a new drug called ASP3082 for adults with advanced cancers. The drug works by blocking harmful proteins. The study will determine the best dose and check for any side effects.
Recruiting1 award Phase 1
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at University of Kansas Medical Center?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.